Skip to content

Tubeless VATS for Peripheral Lung Nodule

Thoracoscopic Surgery Without Chest Tube Placement in Patients With Peripheral Lung Nodules: A Prospective Randomized Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02817048
Enrollment
100
Registered
2016-06-29
Start date
2016-06-30
Completion date
2017-09-30
Last updated
2016-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Solitary Pulmonary Nodule

Brief summary

Chest tube placement after thoracoscopy surgery had been generally accepted as routine procedure for removal of the residual intrapleural fluid and air, however, it would cause post-operative pain, prohibit ambulation after surgery, and prolong the hospital stay. According to the recent studies, omission of chest tube placement after minor thoracoscopic procedures (such as pulmonary wedge resection) had been safe and feasible, and it also reduced the post-operative pain and shortened the hospital stay. We will conduct a prospective randomized trial in National Taiwan University Hospital.

Detailed description

We will enroll 100 patients with peripheral lung nodule who will be randomly assigned to no chest tube placement (tubeless group) or chest tube placement (control group) after thoracoscopic wedge resection with out without lymph adenectomy. The primary endpoints are to compare the post-operative hospital stay and post-operative pain sale between the two groups. The secondary endpoints are to compare the intercostal neuralgia and wound satisfaction one month after surgery between the two groups.

Interventions

PROCEDUREVATS without chest tube placement

Patient received Video-Assisted Thoracic Surgery (VATS) wedge resection for peripheral lung nodule without chest tube placement (Tubeless)

PROCEDUREVATS with chest tube placement

Sponsors

National Taiwan University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* CT revealed peripheral lung nodule, with both size and depth less than 2 cm * Aged 20 to 80 years

Exclusion criteria

* Patients with ventilatory defect * Previous ipsilateral thoracic surgery * Bleeding tendency or anticoagulant use * Comorbidity including congestive heart failure, liver cirrhosis, chronic renal disease * Pregnancy or breast feeding * Immunocompromised or long-term steroid use * Severe infected patient * Patient who can not sign permit

Design outcomes

Primary

MeasureTime frame
Postoperative hospital stay1 week

Secondary

MeasureTime frame
Postoperative pain score1 week
Postoperative intercostal neuralgia1 month
Postoperative wound satisfaction1 month

Other

MeasureTime frame
Hospital cost1 week

Contacts

Primary ContactJin-Shing Chen, MD, PhD
chenjs@ntu.edu.tw886-2-23123456

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026